GO:0034736 cholesterol O-acyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034736 cholesterol O-acyltransferase activity catalyzes the transfer of an acyl group from acyl-CoA to cholesterol, producing a cholesterol ester and CoA.
• The reaction is central to cellular cholesterol homeostasis and to the formation of cholesteryl esters for storage and lipoprotein assembly.
• Key enzymes include SOAT1/ACAT1 and SOAT2/ACAT2, which are endoplasmic reticulum membrane proteins with distinct tissue distributions and functions.
• Defective cholesterol O-acyltransferase activity is linked to Niemann-Pick type C and type D fibroblast phenotypes and to cancer progression.
• The term is often studied alongside lecithin:cholesterol acyltransferase (LCAT), which catalyzes a related but distinct cholesterol esterification reaction in plasma.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of ACAT/LCAT genes in cholesterol metabolism and disease.
Description
Cholesterol O-acyltransferase activity (GO:0034736) is a molecular function that catalyzes the reaction acyl-CoA + cholesterol = a cholesterol ester + CoA. This enzymatic activity is responsible for the intracellular esterification of cholesterol, converting free cholesterol into cholesteryl esters that can be stored in lipid droplets or packaged into lipoproteins. The reaction is fundamental to cholesterol homeostasis and is carried out by sterol O-acyltransferases such as SOAT1 (ACAT1) and SOAT2 (ACAT2) in the endoplasmic reticulum membrane. Researchers study this activity because dysregulation of cholesterol esterification contributes to metabolic disease, cancer, and lysosomal cholesterol trafficking disorders. The term is also frequently compared with lecithin:cholesterol acyltransferase (LCAT) activity, which esterifies cholesterol in plasma using phosphatidylcholine as the acyl donor rather than acyl-CoA. Understanding GO:0034736 therefore requires distinguishing intracellular ACAT-mediated esterification from plasma LCAT-mediated esterification.
cholesterol O-acyltransferase activity At A Glance
| GO ID | GO:0034736 |
|---|---|
| GO term | cholesterol O-acyltransferase activity |
| Ontology | molecular_function |
| Synonym | ACAT activity; acyl-CoA:cholesterol acyltransferase activity; acyl-CoA:cholesterol O-acyltransferase activity; acyl coenzyme A-cholesterol-O-acyltransferase activity; acylcoenzyme A:cholesterol O-acyltransferase activity; cholesterol acyltransferase activity; cholesterol ester synthetase activity; cholesteryl ester synthetase activity |
| Definition | Catalysis of the reaction: acyl-CoA + cholesterol = a cholesterol ester + CoA. |
| Major function | Esterification of cholesterol using acyl-CoA as the acyl donor, producing cholesteryl esters and CoA. |
| Related activity | Lecithin:cholesterol acyltransferase (LCAT) activity, which esterifies cholesterol in plasma using phosphatidylcholine. |
| Representative enzymes | SOAT1/ACAT1, SOAT2/ACAT2, and related acyltransferases. |
| Disease relevance | Niemann-Pick type C/D, cancer progression, and cholesterol trafficking disorders. |
What Is GO:0034736?
In simple terms, cholesterol O-acyltransferase activity is the enzyme function that attaches a fatty acid from acyl-CoA onto cholesterol, making a cholesterol ester. According to the QuickGO definition, it catalyzes the reaction: acyl-CoA + cholesterol = a cholesterol ester + CoA. This activity is synonymous with ACAT activity, acyl-CoA:cholesterol acyltransferase activity, and cholesterol ester synthetase activity. It is a molecular_function term in the Gene Ontology and is distinct from LCAT activity, which uses a different acyl donor and occurs primarily in plasma.
Why Is cholesterol O-acyltransferase activity Important in Cell Biology?
Cholesterol O-acyltransferase activity is essential for maintaining the balance between free cholesterol and cholesteryl esters, a process that influences membrane fluidity, lipid droplet formation, and lipoprotein secretion. Because cholesteryl esters are the storage form of cholesterol, this activity directly affects cellular cholesterol overload and toxicity. In clinical and translational research, altered cholesterol O-acyltransferase activity has been implicated in Niemann-Pick disease fibroblasts and in cancer biology, where it can support tumor cell proliferation and survival. The term also provides a mechanistic anchor for distinguishing intracellular ACAT-driven esterification from plasma LCAT-driven esterification, which is critical when interpreting lipid profiles and designing targeted therapies.
• Maintains cellular cholesterol homeostasis by converting free cholesterol to cholesteryl esters.
• Supports lipid droplet formation and storage of excess cholesterol.
• Contributes to lipoprotein assembly and secretion.
• Defective activity is observed in Niemann-Pick type C and type D fibroblasts.
• Implicated in cancer progression and as a potential diagnostic biomarker.
• Provides a target for modulating cholesterol esterification in metabolic disease.
• Distinguishes intracellular ACAT activity from plasma LCAT activity in lipid studies.
• Enables mechanistic studies of cholesterol trafficking during embryonic development.
• Relevant to esophageal squamous cell carcinoma and other cancers with reprogrammed cholesterol metabolism.
• Supports research on apolipoprotein regulation of cholesterol esterification.
Molecular Mechanism of cholesterol O-acyltransferase activity
Substrate recognition and acyl-CoA binding
In simple terms: The enzyme first grabs a fatty acid carrier called acyl-CoA and a cholesterol molecule.
Cholesterol O-acyltransferase activity requires two substrates: acyl-CoA, which provides the acyl group, and cholesterol, which provides the hydroxyl acceptor. The enzyme binds acyl-CoA and positions the cholesterol molecule so that the 3-hydroxyl group can attack the acyl-CoA thioester. This step is membrane-associated because cholesterol and acyl-CoA are hydrophobic or amphipathic molecules that partition into lipid bilayers.
Catalytic transfer and product release
In simple terms: The fatty acid is transferred onto cholesterol, and the products are released.
The catalytic step transfers the acyl group from acyl-CoA to the 3-hydroxyl group of cholesterol, yielding a cholesterol ester and free CoA. The cholesterol ester product is more hydrophobic than free cholesterol and partitions into lipid droplets or lipoprotein particles. CoA is released into the aqueous phase and can participate in other metabolic reactions. This reaction is the defining chemical transformation of GO:0034736.
Distinction from LCAT activity
In simple terms: A different enzyme, LCAT, also makes cholesterol esters but uses a different fatty acid donor.
Lecithin:cholesterol acyltransferase (LCAT) catalyzes cholesterol esterification in plasma using phosphatidylcholine as the acyl donor, not acyl-CoA. LCAT activity is measured as LCAT mass and cholesterol esterification rate, and it is regulated by apolipoproteins such as apoA-I and apoA-II. In contrast, GO:0034736 specifically describes acyl-CoA-dependent cholesterol O-acyltransferase activity, which is primarily intracellular. Researchers must distinguish these activities when interpreting cholesterol esterification data.
Regulation by apolipoproteins and cellular context
In simple terms: Other proteins and the cell environment can change how fast this reaction occurs.
LCAT activity, a related but distinct cholesterol esterification activity, is stimulated by apolipoprotein A-II in the presence of apolipoprotein A-I. DYRK1A overexpression decreases plasma LCAT activity and apolipoprotein A-I levels, showing that kinase signaling can indirectly regulate cholesterol esterification. For acyl-CoA-dependent cholesterol O-acyltransferase activity, the cellular context such as cholesterol availability and endoplasmic reticulum membrane composition influences flux through the reaction. These regulatory layers highlight the importance of specifying which cholesterol esterification activity is being studied.
Key Genes Involved in GO:0034736 cholesterol O-acyltransferase activity
The following genes and proteins are directly or functionally associated with cholesterol O-acyltransferase activity and related cholesterol esterification pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOAT1 | Sterol O-acyltransferase 1 (ACAT1); catalyzes cholesterol esterification using acyl-CoA | Target for cancer and metabolic disease studies; biomarker potential |
| SOAT2 | Sterol O-acyltransferase 2 (ACAT2); contributes to yolk cholesterol trafficking | Embryogenesis and lipoprotein metabolism models |
| LCAT | Lecithin:cholesterol acyltransferase; plasma cholesterol esterification | Distinct from GO:0034736 but often compared; HDL metabolism |
| APOA1 | Apolipoprotein A-I; cofactor for LCAT activity | Regulates plasma cholesterol esterification |
| APOA2 | Apolipoprotein A-II; stimulates LCAT in presence of apoA-I | Modulates cholesterol esterification rate |
| DYRK1A | Dual-specificity tyrosine phosphorylation-regulated kinase 1A | Overexpression decreases LCAT activity and apoA-I |
| LPCAT1 | Lysophosphatidylcholine acyltransferase 1; reprograms cholesterol metabolism | Esophageal squamous cell carcinoma progression |
| NPC1 | Niemann-Pick type C1; cholesterol trafficking | Defective ACAT activity in NPC fibroblasts |
| NPC2 | Niemann-Pick type C2; cholesterol trafficking | Related to NPC disease and ACAT dysfunction |
| CETP | Cholesteryl ester transfer protein; transfers cholesteryl esters | Lipoprotein metabolism context |
| ABCA1 | Cholesterol efflux transporter | Cholesterol homeostasis context |
| ABCG1 | Cholesterol efflux transporter | Cholesterol homeostasis context |
| SREBF2 | Sterol regulatory element-binding transcription factor 2 | Regulates cholesterol metabolism genes |
| NR1H2 | Liver X receptor beta; cholesterol metabolism regulator | Transcriptional control of cholesterol esterification |
| NR1H3 | Liver X receptor alpha; cholesterol metabolism regulator | Transcriptional control of cholesterol esterification |
| SCARB1 | Scavenger receptor class B member 1; HDL receptor | Cholesterol uptake and esterification context |
| APOE | Apolipoprotein E; lipoprotein metabolism | Cholesterol transport and esterification context |
| SOAT1 variant | Alternatively spliced or mutated forms of SOAT1 | Functional dissection of ACAT activity |
How Is cholesterol O-acyltransferase activity Regulated?
Cholesterol O-acyltransferase activity is regulated at multiple levels. Substrate availability of cholesterol and acyl-CoA directly influences flux through the reaction. In plasma, LCAT activity, a related cholesterol esterification activity, is stimulated by apolipoprotein A-II in the presence of apolipoprotein A-I, and LCAT mass correlates with cholesterol esterification rate. DYRK1A overexpression decreases plasma LCAT activity and apolipoprotein A-I levels, demonstrating kinase-dependent regulation of cholesterol esterification. Cellular cholesterol status and endoplasmic reticulum membrane environment also modulate acyl-CoA-dependent cholesterol O-acyltransferase activity. These regulatory mechanisms are important for interpreting experiments that measure cholesterol esterification under different physiological conditions.
cholesterol O-acyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOAT1 | Cancer progression; biomarker and therapeutic target | Cancer cell line knockout and overexpression |
| SOAT2 | Embryonic cholesterol trafficking | Zebrafish embryogenesis model |
| NPC1 | Niemann-Pick type C disease; defective ACAT activity | Patient fibroblasts and CRISPR knockout |
| NPC2 | Niemann-Pick type C2 disease; cholesterol trafficking | Patient fibroblasts and knockout models |
| LPCAT1 | Esophageal squamous cell carcinoma | Knockdown and overexpression in cancer cells |
Niemann-Pick disease and lysosomal cholesterol trafficking
Defective activity of acyl-CoA:cholesterol O-acyltransferase has been documented in Niemann-Pick type C and type D fibroblasts. This finding links GO:0034736 directly to lysosomal cholesterol trafficking disorders and provides a cellular model for studying cholesterol esterification defects. The impaired esterification contributes to cholesterol accumulation and cellular dysfunction in these diseases.
Cancer progression and biomarker potential
Cholesterol acyltransferase-1 has been proposed as a novel diagnostic biomarker and potential therapeutic target for cancer. In esophageal squamous cell carcinoma, LPCAT1 reprogramming of cholesterol metabolism promotes disease progression, indicating that cholesterol esterification pathways are co-opted by tumors. These studies suggest that GO:0034736-related enzymes may support cancer cell proliferation and survival.
Cardiovascular and lipoprotein metabolism
Cholesterol esterification is central to lipoprotein metabolism. LCAT mass and activity are related to cholesterol esterification rate, and apolipoproteins regulate this process. Although LCAT is distinct from acyl-CoA-dependent cholesterol O-acyltransferase activity, both contribute to the pool of cholesteryl esters in circulation and tissues. Dysregulation of these activities can influence HDL metabolism and cardiovascular risk.
From cholesterol O-acyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SOAT1 alter cholesterol esterification? | CRISPR knockout in cancer cell lines |
| How does SOAT2 contribute to embryonic cholesterol trafficking? | Zebrafish knockout or knockdown |
| Can point mutations in SOAT1 affect catalytic activity? | CRISPR point-mutation knock-in |
| Does tagging SOAT1 reveal its subcellular localization? | Tagged knock-in with fluorescent protein |
| Does overexpression of LPCAT1 reprogram cholesterol metabolism? | Overexpression in esophageal cancer cells |
| Is ACAT activity defective in Niemann-Pick fibroblasts? | Patient-derived fibroblasts and CRISPR correction |
How to Study the cholesterol O-acyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled acyl-CoA assay | Cholesterol O-acyltransferase activity | Enzymatic characterization |
| LCAT mass assay | LCAT protein levels and activity | Plasma cholesterol esterification |
| Lipidomics (mass spectrometry) | Cholesteryl ester and free cholesterol levels | Pathway flux analysis |
| CRISPR knockout screen | Gene requirement for cholesterol esterification | Regulator discovery |
| CRISPR point-mutation knock-in | Effect of specific mutations on activity | Structure-function studies |
| Fluorescent tagging | Subcellular localization | ER and lipid droplet imaging |
| Zebrafish embryogenesis assay | Cholesterol trafficking during development | Developmental biology |
| Cancer cell proliferation assay | Impact of cholesterol esterification on growth | Oncology research |
Enzymatic activity assays
Cholesterol O-acyltransferase activity can be measured by monitoring the conversion of radiolabeled acyl-CoA and cholesterol to cholesteryl esters. LCAT activity, a related but distinct activity, is measured using LCAT mass and cholesterol esterification rate assays. These biochemical methods provide direct readouts of GO:0034736 function in cell lysates or membrane fractions.
CRISPR-based genetic screens
CRISPR knockout and point-mutation screens can identify genes required for cholesterol O-acyltransferase activity and cholesterol homeostasis. Libraries targeting lipid metabolism genes enable unbiased discovery of regulators. These screens are particularly useful for linking candidate genes to cholesterol esterification phenotypes.
Lipidomics and cholesterol quantification
Mass spectrometry-based lipidomics can quantify cholesteryl esters and free cholesterol, providing a downstream readout of cholesterol O-acyltransferase activity. These methods are essential for validating genetic perturbations and for comparing ACAT versus LCAT contributions to cholesterol ester pools.
Imaging and subcellular localization
Fluorescent tagging of SOAT1 or SOAT2 allows visualization of endoplasmic reticulum localization and lipid droplet association. Imaging approaches help connect cholesterol O-acyltransferase activity to cellular cholesterol trafficking and storage.
How CRISPR Can Be Used to Study GO:0034736 cholesterol O-acyltransferase activity
Knockout
CRISPR knockout of SOAT1 or SOAT2 eliminates cholesterol O-acyltransferase activity, allowing researchers to test its role in cholesterol homeostasis, lipid droplet formation, and cancer cell growth. Knockout models are essential for distinguishing the contributions of individual acyltransferases from related activities such as LCAT.
Point Mutation
CRISPR point-mutation knock-in can introduce catalytic-dead or hypomorphic mutations in SOAT1 or SOAT2 to dissect structure-function relationships. These models help identify residues required for acyl-CoA binding and catalysis, and they can reveal separation-of-function phenotypes.
Knock-in
Tagged knock-in of SOAT1 or SOAT2 with fluorescent or affinity tags enables real-time localization and interaction studies. Knock-in of disease-associated variants can model how specific mutations affect cholesterol O-acyltransferase activity in relevant cell types.
Overexpression
Overexpression of SOAT1, SOAT2, or LPCAT1 can drive cholesterol esterification and reprogram cholesterol metabolism, as shown in esophageal squamous cell carcinoma models. Overexpression studies are useful for testing whether increased cholesterol O-acyltransferase activity is sufficient to promote proliferation or lipid storage.
How EDITGENE Supports cholesterol O-acyltransferase activity Research
Researchers studying cholesterol O-acyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in cholesterol esterification, lipid storage, or disease progression. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations of SOAT1, SOAT2, LCAT, and related genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for cholesterol O-acyltransferase activity research.
Frequently Asked Questions About cholesterol O-acyltransferase activity
What is cholesterol O-acyltransferase activity?
Cholesterol O-acyltransferase activity (GO:0034736) is a molecular function that catalyzes the reaction acyl-CoA + cholesterol = a cholesterol ester + CoA, using acyl-CoA as the acyl donor.
What genes are involved in cholesterol O-acyltransferase activity?
Key genes include SOAT1 (ACAT1) and SOAT2 (ACAT2), which encode sterol O-acyltransferases that catalyze cholesterol esterification. LCAT is a related but distinct plasma enzyme.
How is cholesterol O-acyltransferase activity different from LCAT activity?
Cholesterol O-acyltransferase activity uses acyl-CoA as the acyl donor and is primarily intracellular, whereas LCAT uses phosphatidylcholine and acts in plasma.
What diseases are linked to cholesterol O-acyltransferase activity?
Defective activity has been observed in Niemann-Pick type C and type D fibroblasts, and cholesterol acyltransferase-1 has been implicated in cancer.
How can I measure cholesterol O-acyltransferase activity?
Biochemical assays using radiolabeled acyl-CoA and cholesterol, lipidomics, and LCAT mass assays for the related plasma activity are commonly used.
What is the role of SOAT1 in cancer?
SOAT1 (cholesterol acyltransferase-1) has been proposed as a diagnostic biomarker and therapeutic target in cancer, supporting cholesterol esterification for tumor growth.
Does SOAT2 have a developmental role?
SOAT2 contributes to yolk cholesterol trafficking during zebrafish embryogenesis, indicating a role in developmental cholesterol transport.
Can CRISPR be used to study cholesterol O-acyltransferase activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of SOAT1, SOAT2, and related genes in cholesterol esterification.
What is the relationship between LPCAT1 and cholesterol metabolism?
LPCAT1 reprogramming of cholesterol metabolism promotes esophageal squamous cell carcinoma progression, linking acyltransferase activity to cancer.
How is LCAT activity regulated?
LCAT activity is stimulated by apolipoprotein A-II in the presence of apolipoprotein A-I, and DYRK1A overexpression decreases LCAT activity and apoA-I levels.
Conclusion
Cholesterol O-acyltransferase activity (GO:0034736) is a fundamental molecular function that converts free cholesterol into cholesteryl esters using acyl-CoA. Its dysregulation is linked to Niemann-Pick disease, cancer progression, and lipoprotein metabolism, making it a key target for metabolic and oncological research. Distinguishing this activity from LCAT-mediated plasma esterification is essential for accurate interpretation of cholesterol esterification data. CRISPR-based cell models provide powerful tools to dissect the causal roles of SOAT1, SOAT2, and related genes in health and disease.
References
- 1. Jonas A. 2000. Lecithin cholesterol acyltransferase.. Biochim Biophys Acta 1529(1-3):245-56 PMID: 11111093
- 2. Mao S et al.. 2025. Cholesterol acyltransferase-1: A novel diagnostic biomarker and potential therapeutic target for cancer.. J Steroid Biochem Mol Biol 253:106820 PMID: 40544892
- 3. Chang NY et al.. 2016. Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis.. PLoS One 11(12):e0167644 PMID: 27936201
- 4. Tao M et al.. 2021. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.. Cell Death Dis 12(9):845 PMID: 34518524
- 5. Tlili A et al.. 2013. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.. Mol Genet Metab 110(3):371-7 PMID: 23920041
- 6. Chen CH et al.. 1986. Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I.. Eur J Biochem 155(3):589-94 PMID: 3082628
- 7. Byers DM et al.. 1989. Defective activity of acyl-CoA:cholesterol O-acyltransferase in Niemann-Pick type C and type D fibroblasts.. Biochem J 262(3):713-9 PMID: 2590161
- 8. Albers JJ et al.. 1981. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.. J Lipid Res 22(8):1206-13 PMID: 7320631
